Legal experts, doctors and activists brought together by NGO Indian drug users' forum (IDUF) today expressed concern over the growing rate of Hepatitis C in the country at a function held here to mark the World Hepatitis Day.
Citing a WHO report, the health activists said nearly four lakh Indians have been tested positive for Hepatitis C, leading to 96,000 annual deaths due to the viral infection.
The report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
The activists also accused the government of failing to formulate a policy to contain the disease.
"The failure of the Health Ministry to initiate steps to prevent the viral infection and proper treatment facilities is one of the reasons for spreading of the disease in India. It is time that we hold the government accountable for protecting public health," said Anand Grover, lawyer-activist and Special Rapporteur in UNHRC.
A WHO report titled 'Global policy report on prevention and control of viral Hepatitis' highlights non-collaboration of the government with civil society groups to develop and implement viral hepatitis prevention and control programme.
"One vial of interferon alfa by a private drug company costs Rs 23,100. Multiply the figure with 48 weeks and that's how much initial treatment would cost," said Loon Gangte of Delhi Network of Positive People, a group working for the welfare for people suffering from HIV+.
He is of the view that talking more about Hepatitis C and creating an awareness campaign like HIV-AIDS will get things moving.
"Training health care providers, establishing national treatment guidelines, introducing medication...Are some of the steps the Health Ministry must take, until a comprehensive national programme for prevention, control and treatment of viral hepatitis is launched," an activist said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
